CDNA vs NEO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 21, 2026
CDNA
NEO
Investment Advisor Scores
NEO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | NEO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 156.25 | 222.2222 | CDNA |
| PEG Ratio | -0.12 | 2.0871 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 52.2% | 11.2% | CDNA |
| Earnings Growth | 0.0% | 130.6% | NEO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 30.1/100 | 33.1/100 | NEO |
| Profit Margin | 24.2% | -6.8% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | SELL | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81
NEO
NeutralMixed signals - no dominant trend phase, RSI 48
Fundamentals Snapshot
| Metric | CDNA | NEO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 51.3 | 52.6 |
| Trailing P/E | 30.8 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.1% |
| Gross Margin | 0.7% | 0.4% |
| Operating Margin | 0.0% | 0.0% |
| EPS | 2.11 | -0.39 |
| Dividend Yield | — | — |